| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.055 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.036 | 0.8 |